Items-$0.00
Email:sales@ruixibiotech.com
Tel.:02988811435
TAK285 CAS：871026-44-7
TAK285
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-C-515 | 50MG | 365.00 | + Add to cart |
|
| R-C-515 | 100MG | 650.00 | + Add to cart |
|
| R-C-515 | 200MG | 1215.00 | + Add to cart |
|
|
|
||||
Product description
TAK-285 is a potent,selective,ATP-competitive and orally active HER2 and EGFR(HER1)inhibitor with IC50 of 17 nM and 23 nM,respectively.TAK-285 is >10-fold selectivity for HER1/2 than HER4,and less potent to MEK1/5,c-Met,Aurora B,Lck,CSK etc.TAK-285 has effective antitumor activity.TAK-285 can cross the blood-brain barrier(BBB).
| Appearance | N/A |
|---|---|
| Molecular Weight | N/A |
| Purity | >95% |
| PDI by GPC | <1.5 |
| Solubility | DMSO |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
MADS---TAK285 Related Product
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com
